Showing results (1221-1230 of 2,812) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|March 17, 2016
A drug safety evaluation of mirabegron in the management of overactive bladderDudley Robinson, Ganesh Thiagamoorthy, Linda CardozoExpert Opinion on Drug Safety|March 10, 2016
The safety of mineralocorticoid receptor antagonists (MRAs) in patients with heart failureBertram Pitt, Patrick RossignolExpert Opinion on Drug Safety|March 11, 2016
The use and risks of antibiotics in critically ill patientsKerina J Denny, Menino O Cotta, Suzanne L Parker, et al.Expert Opinion on Drug Safety|December 9, 2014
Safety of off-label biologicals in systemic lupus erythematosusMartin Aringer, Josef S SmolenExpert Opinion on Drug Safety|December 9, 2014
Therapeutic strategies to prevent and manage dyskinesias in Parkinson's diseaseManuela Pilleri, Angelo AntoniniExpert Opinion on Drug Safety|October 6, 2015
Aims and approaches of Web-RADR: a consortium ensuring reliable ADR reporting via mobile devices and new insights from social mediaRajesh Ghosh, David LewisExpert Opinion on Drug Safety|October 6, 2015
Statins and their increased risk of inducing diabetesAris P Agouridis, Michael S Kostapanos, Moses S ElisafExpert Opinion on Drug Safety|November 17, 2015
Safety of monoclonal antibodies and related therapeutic proteins for the treatment of neovascular macular degeneration: addressing outstanding issuesFocke Ziemssen, Bianka Sobolewska, Heidrun Deissler, et al.Expert Opinion on Drug Safety|November 13, 2015
Tazarotene foam, 0.1%, for the treatment of acneJaclyn A Smith, Swetha Narahari, Dane Hill, et al.Pageof 282